A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome

BACKGROUND: Up to half of patients with localized prostate cancer experience biochemical relapse within 10 years after definitive radiotherapy. The aim of this prospective study was to investigate the toxicity, dose to the organs at risk (OARs), and efficacy of dose-intensified focal salvage radioth...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryg, Una, Seierstad, Therese, Nilsen, Line Brennhaug, Hellebust, Taran Paulsen, Djupvik, Linda Holth, Gustafson, Hilde, Hydal, Jørgen, Kishan, Amar U., Hole, Knut Håkon, Lilleby, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022104/
https://www.ncbi.nlm.nih.gov/pubmed/35463376
http://dx.doi.org/10.3389/fonc.2022.861127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022104/
https://www.ncbi.nlm.nih.gov/pubmed/35463376
http://dx.doi.org/10.3389/fonc.2022.861127

Ejemplares similares